Major drugmakers turn to China for licensing deals
Rona Therapeutics said on Tuesday it has signed a licensing deal worth up to $1.16 billion with Swiss drugmaker Roche for an experimental obesity drug candidate.
Rona Therapeutics said on Tuesday it has signed a licensing deal worth up to $1.16 billion with Swiss drugmaker Roche for an experimental obesity drug candidate.